Treatment and respiratory support modes for neonates with respiratory distress syndrome

References

• Klotz D, Porcaro U, Fleck T, et al. European perspective on less invasive surfactant administration—a survey. Eur J Pediatr. 2017;176:147–154.
   PubMed Web of Science ®Google Scholar
• Parad RB, Davis JM, Lo J, et al. Prediction of respiratory outcome in extremely low gestational age infants. Neonatology. 2015;107:241–248. Demonstrates that BPD is a poor predictor of chronic respiratory morbidity.
   PubMed Web of Science ®Google Scholar
• Steinhorn R, Davis JM, Göpel W, et al. Chronic pulmonary insufficiency of prematurity: developing optimal endpoints for drug development. J Pediatr. 2017;191:15–21.
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Chida S, Watabe Y, et al. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1980;1:55–59.
   PubMed Web of Science ®Google Scholar
• Sweet DG, Halliday HL, Speer CP. Surfactant therapy for neonatal respiratory distress syndrome in 2013. J Maternal-Fetal Neonatal Med. 2014;26:27–29.
   Web of Science ®Google Scholar
• Sardesai S, Biniwale M, Wertheimer F, et al. Evolution of surfactant therapy for respiratory distress syndrome: past, present and future. Pediatr Res. 2017;81:240–248.
   PubMed Web of Science ®Google Scholar
• Lal MK, Sinha SK. Lucinactant (SurfaxinTM) for prevention and treatment of respiratory distress syndrome in newborns. Pediatr Health. 2009;3:427–434.
   Google Scholar
• Jain K, Nangia S, Ballambattu VB, et al. Goat lung surfactant for treatment of respiratory distress syndrome among preterm neonates: a multi-site randomized non-inferiority trial. J Perinatol. 2019;39:3–12.
   PubMed Web of Science ®Google Scholar
• Singh N, Hawley KL, Viswanathan K. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis. Pediatrics. 2011;128:e1588–95.
   PubMed Web of Science ®Google Scholar
• Singh N, Halliday HL, Stevens TP, et al. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2015;11:CD010249.
   Google Scholar
• Tridente A, De Martino L, De Luca D. Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes. Respir Res. 2019;20:28.
   PubMed Web of Science ®Google Scholar
• Foligno S, De Luca D. Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of pathophysiological plausibility of the effects on extra pulmonary outcomes. Respir Res. 2020;21:8.
   PubMed Web of Science ®Google Scholar
• Sinha SK, Lacaze-Masmonteil T, Valls I, et al. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics. 2005;115:1030–1038.
   PubMed Web of Science ®Google Scholar
• Moya F, Sinha S, Gadzinowski J, et al. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials. Pediatrics. 2007;119:e1361–70.
   PubMed Web of Science ®Google Scholar
• Soll RF. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2000;2:CD000144.
   Google Scholar
• Walther FJ, Gordon LM, Waring AJ. Advances in synthetic lung surfactant protein technology. Expert Rev Respir Med. 2019;13:499–501.
   PubMed Web of Science ®Google Scholar
• Ricci F, Murgia X, Razzetti R, et al. In vitro and in vivo comparison between poractant alfa and the new generation synthetic surfactant CHF5633. Pediatr Res. 2017;81:369–375.
   PubMed Web of Science ®Google Scholar
• Sweet DG, Turner MA, Stranák Z, et al. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 2017;102:F497–503.
   PubMed Web of Science ®Google Scholar
• Exas TH, Esearch NE. Early surfactant for neonates with mild to moderate respiratory distress syndrome: A multicenter, randomized trial. J Pediatr. 2004;144:804–808.
   PubMed Web of Science ®Google Scholar
• Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2004;3:CD003063.
   Google Scholar
• Dargaville PA, Aiyappan A, De Paoli AG, et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed. 2013;98:122–126.
   PubMed Web of Science ®Google Scholar
• Amigoni A, Pettenazzo A, Stritoni V, et al. Surfactants in acute respiratory distress syndrome in infants and children: past, present and future. Clin Drug Investig. 2017;37:729–736.
   PubMed Web of Science ®Google Scholar
• Yeh TF, Chen CM, Wu SY, et al. Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2016;193:86–95.
   PubMed Web of Science ®Google Scholar
• Stevens TP, Harrington EW, Blennow M, et al. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;4:CD003063.
   PubMed Web of Science ®Google Scholar
• Brix N, Sellmer A, Jensen MS, et al. Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: A cohort study. BMC Pediatr. 2014;14:1–8.
   PubMed Web of Science ®Google Scholar
• Jeffreys E, Hunt K, Dassios T, et al. UK survey of less invasive surfactant administration. Arch Dis Child Fetal Neonatal Ed. 2019;104:F567.
   PubMed Web of Science ®Google Scholar
• Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome - 2019 update. Neonatology. 2019;115:432–450.
   PubMed Web of Science ®Google Scholar
• Niemarkt HJ, Kuypers E, Jellema R, et al. Effects of less-invasive surfactant administration on oxygenation, pulmonary surfactant distribution, and lung compliance in spontaneously breathing preterm lambs. Pediatr Res. 2014;76:166–170.
   PubMed Web of Science ®Google Scholar
• Jourdain G, De Tersant M, Dell’Orto V, et al. Continuous positive airway pressure delivery during less invasive surfactant administration: a physiologic study. J Perinatol. 2018;38:271–277.
   PubMed Web of Science ®Google Scholar
• Aldana-Aguirre JC, Pinto M, Featherstone RM, et al. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2017;102:F17–23.
   PubMed Web of Science ®Google Scholar
• Rigo V, Lefebvre C, Broux I. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis. Eur J Pediatr. 2016;175:1933–1942.
   PubMed Web of Science ®Google Scholar
• Isayama T, Iwami H, McDonald S, et al. Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: A systematic review and meta-analysis. JAMA. 2016;316:611–624.
   PubMed Web of Science ®Google Scholar
• Göpel W, Kribs A, Ziegler A, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378:1627–1634.
   PubMed Web of Science ®Google Scholar
• Lewis JF, Ikegami M, Jobe AH, et al. Aerosolized surfactant treatment of preterm lambs. J Appl Physiol. 1991;70:869–876.
   PubMed Web of Science ®Google Scholar
• Berggren E, Liljedahl M, Winbladh B, et al. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr. 2000;89:460–465.
   PubMed Web of Science ®Google Scholar
• Minocchieri S, Berry CA, Pillow JJ. Nebulised surfactant to reduce severity of respiratory distress: A blinded, parallel, randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2019;104:F313–9.
   PubMed Web of Science ®Google Scholar
• Jorch G, Hartl H, Roth B, et al. To the editor: surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatr Pulmonol. 1997;24:222–224.
   PubMed Web of Science ®Google Scholar
• Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11:CD00111456.
   Google Scholar
• Dargaville PA, Aiyappan A, De Paoli AG, et al. Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences. Neonatology. 2013;104:8–14.
   PubMed Web of Science ®Google Scholar
• Raimondi F, Yousef N, Migliaro F, et al. Point-of-care lung ultrasound in neonatology: classification into descriptive and functional applications. Pediatr Res. 2018. [Epub ahead of print]. DOI:10.1038/s41390-018-0114-9.
   PubMedGoogle Scholar
• Brat R, Yousef N, Klifa R, et al. Lung ultrasound score to evaluate oxygenation and surfactant need in neonates treated with continuous positive airway pressure. JAMA Pediatr. 2015;168:e151797.
   Google Scholar
• De Martino L, Yousef N, Ben-Ammar R, et al. Lung ultrasound score predicts surfactant need in extremely preterm neonates. Pediatrics. 2018;142:e20180463.
   PubMed Web of Science ®Google Scholar
• Jobe AH. Mechanisms of lung injury and bronchopulmonary dysplasia. Am J Perinatol. 2016;33:1076–1078.
   PubMed Web of Science ®Google Scholar
• Doyle LW, Cheong JL, Ehrenkranz RA, et al. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2017;10:CD001145.
   PubMedGoogle Scholar
• Doyle LW, Cheong JL, Ehrenkranz RA, et al. Early (<8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2017;10:CD001146.
   PubMedGoogle Scholar
• Hunt KA, Dassios T, Ali K, et al. Prediction of bronchopulmonary dysplasia development. Arch Dis Child Fetal Neonatal Ed. 2018;103:F598–9.
   PubMed Web of Science ®Google Scholar
• Zeng L, Tian J, Song F, et al. Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: A network meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2018;103:F506–11.
   PubMed Web of Science ®Google Scholar
• Baud O, Maury L, Lebail F, et al. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (premiloc): A double-blind, placebo-controlled, multicentre, randomised trial. Lancet. 2016;387:1827–1836.
   PubMed Web of Science ®Google Scholar
• Onland W, Cools F, Kroon A, et al. Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or bronchopulmonary dysplasia among very preterm infants receiving mechanical ventilation: A randomized clinical trial. JAMA. 2019;321:354–363.
   PubMed Web of Science ®Google Scholar
• Shah VS, Ohlsson A, Halliday HL, et al. Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates. Cochrane Database Syst Rev. 2017;1:CD001969.
   PubMedGoogle Scholar
• Bassler D, Plavka R, Shinwell ES, et al. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. New Engl J Med. 2015;373:1497–1506.
   PubMed Web of Science ®Google Scholar
• Bassler D, Shinwell ES, Hallman M, et al. Neonatal European study of inhaled steroids trial. Long-term effects of inhaled budesonide for bronchopulmonary dysplasia. New Engl J Med. 2018;378:148–157.
   PubMed Web of Science ®Google Scholar
• Onland W, Offringa M, van Kaam A. Late (>/= 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2017;8:CD002311.
   PubMedGoogle Scholar
• Venkataraman R, Kamaluddeen M, Hasan SU, et al. Intratracheal administration of budesonide surfactant in prevention of bronchopulmonary dysplasia in very low birth weight infants: A systematic review and meta-analysis. Pediatr Pulmonol. 2017;52:968–975.
   PubMed Web of Science ®Google Scholar
• Gappa M, Gartner M, Poets CF, von der Hardt H. Effects of salbutamol delivery from a metered dose inhaler versus jet nebulizer on dynamic lung mechanics in very preterm infants with chronic lung disease. Pediatr Pulmonol. 1997;23:442–448.
   PubMed Web of Science ®Google Scholar
• Ng G, da Silva O, Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2016;12:CD003214.
   PubMed Web of Science ®Google Scholar
• Sadeghnia A, Beheshti BK, Mohammadizadeh M. The effect of inhaled budesonide on the prevention of chronic lung disease in premature neonates with respiratory distress syndrome. Int J Prevent Med. 2018;9:15.
   PubMed Web of Science ®Google Scholar
• Dehdashtian M, Malakian A, Aramesh MR, et al. Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial. Ital J Pediatr. 2016;42:6.
   PubMed Web of Science ®Google Scholar
• De Luca D, Cogo P, Zecca E, et al. Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review. Eur Respir J. 2011;37:678–689.
   PubMed Web of Science ®Google Scholar
• Semberova J, O’Donnell SM, Franta J, et al. Inhaled nitric oxide in preterm infants with prolonged preterm rupture of the membranes: A case series. J Perinatol. 2015;35:304–306.
   PubMed Web of Science ®Google Scholar
• Ellsworth KR, Ellsworth MA, Weaver AL, et al. Association of early inhaled nitric oxide with the survival of preterm neonates with pulmonary hypoplasia. JAMA Pediatr. 2018;172:e180761.
   PubMed Web of Science ®Google Scholar
• Carey WA, Weaver AL, Mara KC, et al. Inhaled nitric oxide in extremely premature neonates with respiratory distress syndrome. Pediatrics. 2018;141:e20173108.
   PubMed Web of Science ®Google Scholar
• Askie LM, Ballard RA, Cutter GR, et al. Inhaled nitric oxide in preterm infants: an individual patient data meta-analysis of randomized trials. Pediatrics. 2011;128:729–739.
   PubMed Web of Science ®Google Scholar
• Cole FS, Alleyne C, Barks JD, et al. NIH consensus development conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics. 2011;127:363–369.
   PubMed Web of Science ®Google Scholar
• Dixon F, Ziegler DS, Bajuk B, et al. Treatment with nitric oxide in the neonatal intensive care unit is associated with increased risk of childhood cancer. Acta Paediatr. 2018;107:2092–2098.
   PubMed Web of Science ®Google Scholar
• Kinsella JP, Steinhorn RH, Krishnan US, et al. Recommendations for the use of inhaled nitric oxide therapy in premature newborns with severe pulmonary hypertension. J Pediatr. 2016;170:312–314.
   PubMed Web of Science ®Google Scholar
• Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for endotracheal extubation in preterm infants. Cochrane Database Syst Rev. 2010;12:CD000139.
   Google Scholar
• Kassim Z, Greenough A, Rafferty GF. Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants. Eur J Pediatr. 2009;168:1491–1495.
   PubMed Web of Science ®Google Scholar
• Williams EE, Hunt KA, Jeyakara J, et al. Electrical activity of the diaphragm following a loading dose of caffeine citrate in ventilated preterm infants. Pediatr Res. 2020;87:740–744. [Epub ahead of print].
   Web of Science ®Google Scholar
• Abdel-Hady H, Nasef N, Shabaan AE, et al. Caffeine therapy in preterm infants. World J Clin Pediatr. 2015;4:81–93.
   PubMedGoogle Scholar
• Schmidt B, Roberts RS, Davis P, et al. Caffeine for Apnea of prematurity trial G. Caffeine therapy for apnea of prematurity. New Engl J Med. 2006;354:2112–2121.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Davis P, et al. Caffeine for Apnea of prematurity trial. Long-term effects of caffeine therapy for apnea of prematurity. New Engl J Med. 2007;357:1893–1902.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Anderson PJ, et al. Caffeine for Apnea of prematurity trial. Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity: an 11-year follow-up of the cap randomized clinical trial. JAMA Pediatr. 2017;171:564–572.
   PubMed Web of Science ®Google Scholar
• Lodha A, Entz R, Synnes A, et al. Investigators of the Canadian Neonatal N, the Canadian Neonatal follow-up. Early caffeine administration and neurodevelopmental outcomes in preterm infants. Pediatrics. 2019;143(1):e20181348. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Hallman M, Bry K, Hoppu K, et al. Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med. 1992;326:1233–1239.
   PubMed Web of Science ®Google Scholar
• Hallman M, Jarvenpaa AL, Pohjavuori M. Respiratory distress syndrome and inositol supplementation in preterm infants. Arch Dis Child. 1986;61:1076–1083.
   PubMed Web of Science ®Google Scholar
• Phelps DL, Ward RM, Williams RL, et al. Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res. 2016;80:209–217.
   PubMed Web of Science ®Google Scholar
• Borghesi A, Cova C, Gazzolo D, et al. Stem cell therapy for neonatal diseases associated with preterm birth. J Clin Neonatol. 2013;2:1–7.
   PubMedGoogle Scholar
• Shetty S, Greenough A. Review finds insufficient evidence to support the routine use of heated, humidified, high-flow nasal cannula use in neonates. Acta Paediatr. 2014;103:898–903.
   PubMed Web of Science ®Google Scholar
• Jeffreys E, Hunt K, Dassios T, et al. Diaphragm electromyography results at different high flow nasal cannula flow rates. Eur J Pediatr. 2019;178:1237–1242.
   PubMed Web of Science ®Google Scholar
• Manley BJ, Owen LS, Doyle LW, et al. High-flow nasal cannulae in very preterm infants after extubation. N Engl J Med. 2013;369:1425–1433.
   PubMed Web of Science ®Google Scholar
• Yoder B, Stoddard R, Li M, et al. Heated, humidified high-flow nasal cannula versus nasal CPAP for respiratory support in neonates. Pediatrics. 2013;131:e1482–90.
   PubMed Web of Science ®Google Scholar
• Murki S, Singh J, Khant C, et al. High-flow nasal cannula versus nasal continuous positive airway pressure for primary respiratory support in preterm infants with respiratory distress: a randomised controlled trial. Neonatology. 2018;113:235–241.
   PubMed Web of Science ®Google Scholar
• Teoh S, Clyde E, Dassios T, et al. Factors contributing to the failure of humidified high flow nasal cannulae. Acta Paediatr. 2018;107:1826–1827.
   PubMed Web of Science ®Google Scholar
• Morley CJ, Davis PG, Doyle LW, et al. Nasal CPAP or intubation at birth for very preterm infants. New Engl J Med. 2008;358:700–708.
   PubMed Web of Science ®Google Scholar
• Support Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. New Engl J Med. 2010;362:1970–1979.
   PubMed Web of Science ®Google Scholar
• Stevens TP, Finer NN, Carlo WA, et al. Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). J Pediatr. 2014;165:240–249.
   PubMed Web of Science ®Google Scholar
• Dunn MS, Kaempf J, de Klerk A, et al. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics. 2011;128:e1069–76.
   PubMed Web of Science ®Google Scholar
• Schmölzer GM, Kumar M, Pichler G, et al. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ. 2013;347:f5980.
   PubMed Web of Science ®Google Scholar
• Fischer HS, Buhrer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics. 2013;132:e1351–60.
   PubMed Web of Science ®Google Scholar
• Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev. 2003;2:CD000143 21.
   Google Scholar
• Chowdhury O, Wedderburn CJ, Duffy D, et al. CPAP review. Eur J Pediatr. 2012;171:1441–1448.
   PubMed Web of Science ®Google Scholar
• O’Brien K, Campbell C, Brown L, et al. Infant flow biphasic nasal continuous positive airway pressure (BP-NCPAP) vs infant flow NCPAP for the facilitation of extubation in infants <1250 grams: a randomised controlled trial. BMC Pediatr. 2012;12:43.
   PubMed Web of Science ®Google Scholar
• Victor S, Roberts SA, Mitchell S, et al. Biphasic positive airway pressure or continuous positive airway pressure: a randomised trial. Pediatrics. 2016;138(2):e20154095.
   PubMed Web of Science ®Google Scholar
• Lemyre B, Davis PG, De Paoli AG, et al. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (nCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev. 2017;2:CD003212.
   PubMed Web of Science ®Google Scholar
• Gizzi C, Montecchia F, Panetta V, et al. Is synchronised NIPPV more effective than NIPPV and nCPAP in treating apnoea of prematurity (APO)? A randomised cross-over trial. Arch Dis Child Fetal Neonatal Ed. 2015;100:F17–23.
   PubMed Web of Science ®Google Scholar
• Charles E, Hunt KA, Rafferty GF, et al. Work of breathing during HHHFNC and synchronised NIPPV following extubation. Eur J Pediatr. 2019;178:105–110.
   PubMed Web of Science ®Google Scholar
• Millar D, Lemyre B, Kirpalani H, et al. A comparison of bilevel and ventilator delivered non invasive respiratory support. Arch Dis Child Fetal Neonatal Ed. 2016;101:F21–5.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim HS, Jung YH, et al. Non-invasive neutrally adjusted ventilatory assist in preterm infants: a randomised phase II crossover trial. Arch Dis Child Fetal Neonatal Ed. 2015;100:F507–13.
   PubMed Web of Science ®Google Scholar
• Gibu CK, Cheng PY, Ward RJ, et al. Feasibility and physiological effects of non-invasive neurally adjusted ventilatory assist in preterm infants. Pediatr Res. 2017;82:650–657.
   PubMed Web of Science ®Google Scholar
• Yonehara K, Ogawa R, Kamei Y, et al. Non-invasive neurally adjusted ventilatory assist versus nasal intermittent positive pressure ventilation in preterm infants born before 30 weeks gestation. Pediatr Int. 2018;60:957–961.
   PubMed Web of Science ®Google Scholar
• De Luca D, Dell’Orto V. Non-invasive high frequency oscillatory ventilation in neonates: review of physiology, biology and clinical data. Arch Dis Child Fetal Neonatal Ed. 2016;101:F565–70.
   PubMed Web of Science ®Google Scholar
• Iranpour R, Armanian AM, Abedi AR, et al. Nasal high frequency oscillatory ventilation (nHFOV) versus nasal continuous positive airway pressure (nCPAP) as an initial therapy for respiratory distress syndrome (RDS) in preterm and near-term infants. BMJ Paediatr Open. 2019;3:e000443.
   PubMedGoogle Scholar
• Shehadeh AM. Non-invasive respiratory support for preterm infants following extubation from mechanical ventilation. Pediatr Neonatol. 2020;61:142-147. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Li J, Li X, Huang X, et al. Non-invasive high frequency oscillatory ventilation as respiratory support in preterm infants: a meta-analysis of randomized controlled trials. Respir Res. 2019;20:58.
   PubMed Web of Science ®Google Scholar
• Shi Y, De Luca D, NASal OscillatioN post-Extubation (NASONE) Study Group. Continuous positive airway pressure (CPAP) vs non-invasive positive pressure ventilation (NIPPV) vs non-invasive high frequency oscillation ventilation (NHFOV) as post-extubation support in preterm neonates: protocol for an assessor-blinded, multicenter, randomized controlled trial. BMC Pediatr. 2019;19:256.
   PubMed Web of Science ®Google Scholar
• Greenough A, Rossor TE, Sundaresan A, et al. Synchronized mechanical ventilation for respiratory support in newborn infants. Cochrane Database Rev. 2016;9:CD000456.
   PubMedGoogle Scholar
• Reyes ZC, Claure N, Tauscher MK, et al. Randomised controlled trial comparing synchronized intermittent mandatory ventilation and synchronized intermittent mandatory ventilation plus pressure support in preterm infants. Pediatrics. 2006;118:1409–1417.
   PubMed Web of Science ®Google Scholar
• Patel DS, Rafferty GF, Lee S, et al. Work of breathing during SIMV with and without pressure support. Arch Dis Child. 2009;94:434–436.
   PubMed Web of Science ®Google Scholar
• Schulze A, Rieger-Fackeldey E, Gerhardt T, et al. Randomized crossover comparison of proportional assist ventilation and patient-triggered ventilation in extremely low birth weight infants with evolving chronic lung disease. Neonatology. 2007;92:1–7.
   PubMed Web of Science ®Google Scholar
• Bhat P, Patel DS, Hannam S, et al. Crossover study of proportional assist versus assist control ventilation. Arch Dis Child Fetal. 2015;100:F35–8.
   PubMed Web of Science ®Google Scholar
• Shetty S, Bhat P, Hickey A, et al. Proportional assist versus assist control ventilation in premature infants. Eur J Pediatr. 2016;175:57–61.
   PubMed Web of Science ®Google Scholar
• Verbrugghe W, Jorens PG. Neurally adjusted ventilatory assist: a ventilation tool or a ventilation toy? Respir Care. 2011;56:327–335.
   PubMed Web of Science ®Google Scholar
• Stein H, Beck J, Dunn M. Non-invasive ventilation with neutrally adjusted ventilator assist in newborns. Semin Fetal Neonatal Med. 2016;21:154–161.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim HS, Sohn JA, et al. Randomized crossover study of neurally adjusted ventilatory assist in preterm infants. J Pediatr. 2012;161:808–813.
   PubMed Web of Science ®Google Scholar
• Peng W, Zhu H, Shi H, et al. Volume targeted ventilation is more suitable than pressure limited ventilation for preterm infants: a systemic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2014;99:F158–65.
   PubMed Web of Science ®Google Scholar
• Sharma A, Milner AD, Greenough A. Performance of neonatal ventilators in volume targeted ventilation mode. Acta Paediatr. 2007;96:176–180.
   PubMed Web of Science ®Google Scholar
• Patel DS, Rafferty GF, Lee S, et al. Work of breathing and volume targeted ventilation in respiratory distress. Arch Dis Child Fetal Neonatal Ed. 2010;95:F443–6.
   PubMed Web of Science ®Google Scholar
• Patel DS, Sharma A, Prendergast M, et al. Work of breathing and different levels of volume-targeted ventilation. Pediatrics. 2009;123:e679–84.
   PubMed Web of Science ®Google Scholar
• Singh J, Sinha SK, Alsop E, et al. Long term follow- up of very low birthweight infants from a neonatal volume versus pressure mechanical ventilation trial. Arch Dis Child Fetal Neonatal Ed. 2009;94:F360–2.
   PubMed Web of Science ®Google Scholar
• Laubscher B, Greenough A, Costeloe K. Performance of high frequency oscillators. Brit J Inten Care. 1996;6:148–162.
   Google Scholar
• Zivanovic S, Peacock J, Alcazar-Paris M, et al. Late outcomes of a randomised trial of high frequency oscillation in neonates. N Engl J Med. 2014;370:1121–1130.
   PubMed Web of Science ®Google Scholar
• Cools F, Askie SM, Offringa M, et al. Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients’ data. Lancet. 2010;375:2082–2091.
   PubMed Web of Science ®Google Scholar
• De Luca D, van Kaam AH, Tingay DG, et al. The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med. 2017;5:657–666.
   PubMed Web of Science ®Google Scholar
• Ethawi YH, Abou Mehrem A, Minski J, et al. High frequency jet ventilation versus high frequency oscillatory ventilation for pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev. 2016;5:CD010548.
   Google Scholar
• UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet. 1996;348:75–82.
   PubMed Web of Science ®Google Scholar
• Petrou S, Edwards L; UK Collaborative ECMO Trial. Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK collaborative ECMO trial. Arch Dis Child Fetal Neonatal Ed. 2004;89:F263–8.
   PubMed Web of Science ®Google Scholar
• Hintz SR, Suttner DM, Sheehan AM, et al. Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Pediatrics. 2000;106:1339–1343.
   PubMed Web of Science ®Google Scholar
• Roy BJ, Rycus P, Conrad SA, et al. The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the Extracorporeal Life Support Organization (ELSO) Registry. Pediatrics. 2000;106:1334–1338.
   PubMed Web of Science ®Google Scholar
• Lotze A, Knight GR, Martin GR, et al. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr. 1993;122:261–268.
   PubMed Web of Science ®Google Scholar
• Sturrock S, Williams E, Dassios T, et al. Closed loop automated oxygen control in neonates – a review. Acta Paediatr. 2020;109:914-922. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Hunt KA, Dassios T, Greenough A. Proportional assist ventilation (PAV) versus neurally adjusted ventilator assist (NAVA): effect on oxygenation in infants with evolving or established bronchopulmonary dysplasia. Eur J Pediatr. 2020;179(6):901–908. [Epub ahead of print].
   Web of Science ®Google Scholar